Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2022, Vol. 36 ›› Issue (5): 88-92.doi: 10.6040/j.issn.1673-3770.0.2021.185

Previous Articles    

Association between ocular ischemic syndrome and ischemic stroke

LI Man1,2Overview,FENG Xue3, WANG Yanling1Guidance   

  1. 1. Department of Ophthalmology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China;
    2. Department of Anesthesiology, China-Japan Friendship Hospital, Beijing 100029, China;
    3. Department of Ophthalmology, Beijing Jishuitan Hospital, Beijing 100035, China
  • Published:2022-09-20

PDF (PC)

70

Abstract: The vessels of eye and brain have close anatomical connections and similar physiological characteristics. Ocular ischemic syndrome(OIS)is an ischemic eye disease related to carotid artery stenosis, and ischemic stroke is the most representative ischemic cerebrovascular disease. Several studies have shown that OIS-related signs have some predictive value for the occurrence of ischemic stroke. Conversely, various ocular ischemic changes have been found to be secondary to ischemic stroke. This article reviews the findings on the association between OIS and ischemic stroke to promote multidisciplinary cooperation and optimize clinical diagnosis and treatment strategies.

Key words: Ocular ischemic syndrome, Ischemic stroke, Carotid artery stenosis, Hemodynamics, Vascular endothelial growth factor

CLC Number: 

  • R771.3
[1] Cheung CY, Ikram MK, Chen C, et al. Imaging Retina to study dementia and stroke[J]. Prog Retin Eye Res, 2017, 57: 89-107. doi:10.1016/j.preteyeres.2017.01.001.
[2] Gitanjli. Ocular Ischemic Syndrome[M]. Treasure Island(FL): StatPearls Publishing,2021.
[3] Liu LP, Chen WQ, Zhou HY, et al. Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of ischaemic cerebrovascular diseases[J]. Stroke Vasc Neurol, 2020, 5(2): 159-176. doi:10.1136/svn-2020-000378.
[4] Avery MB, Magal I, Kherani A, et al. Risk of stroke in patients with ocular arterial occlusive disorders: a retrospective Canadian study[J]. J Am Heart Assoc, 2019, 8(3): e010509. doi:10.1161/JAHA.118.010509.
[5] Rowe FJ. Stroke survivors' views and experiences on impact of visual impairment[J]. Brain Behav, 2017, 7(9): e00778. doi:10.1002/brb3.778.
[6] London A, Benhar I, Schwartz M. The Retina as a window to the brain-from eye research to CNS disorders[J]. Nat Rev Neurol, 2013, 9(1): 44-53. doi:10.1038/nrneurol.2012.227.
[7] Kaur C, Foulds WS, Ling EA. Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management[J]. Prog Retin Eye Res, 2008, 27(6): 622-647. doi:10.1016/j.preteyeres.2008.09.003.
[8] Patton N, Aslam T, MacGillivray T, et al. Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures[J]. J Anat, 2005, 206(4): 319-348. doi:10.1111/j.1469-7580.2005.00395.x.
[9] Cooper LS, Wong TY, Klein R, et al. Retinal microvascular abnormalities and MRI-defined subclinical cerebral infarction: the Atherosclerosis Risk in Communities Study[J]. Stroke, 2006, 37(1): 82-86. doi:10.1161/01.STR.0000195134.04355.e5.
[10] Vernieri F, Pasqualetti P, Matteis M, et al. Effect of collateral blood flow and cerebral vasomotor reactivity on the outcome of carotid artery occlusion[J]. Stroke, 2001, 32(7): 1552-1558. doi:10.1161/01.str.32.7.1552.
[11] Hofmeijer J, Klijn CJ, Kappelle LJ, et al. Collateral circulation via the ophthalmic artery or leptomeningeal vessels is associated with impaired cerebral vasoreactivity in patients with symptomatic carotid artery occlusion[J]. Cerebrovasc Dis, 2002, 14(1): 22-26. doi:10.1159/000063719.
[12] Terelak-Borys B, Skonieczna K, Grabska-Liberek I. Ocular ischemic syndrome-a systematic review[J]. Med Sci Monit, 2012, 18(8): RA138-RA144. doi:10.12659/msm.883260.
[13] Kobayashi S, Hollenhorst RW, Sundt TM Jr. Retinal arterial pressure before and after surgery for carotid artery Stenosis[J]. Stroke, 1971, 2(6): 569-575. doi:10.1161/01.str.2.6.569.
[14] Sivalingam A, Brown GC, Magargal LE, et al. The ocular ischemic syndrome. Mortality and systemic morbidity[J]. Int Ophthalmol, 1989, 13(3):187-191.
[15] 王露萍, 黄映湘, 王艳玲. 眼缺血综合征研究进展[J]. 山东大学耳鼻喉眼学报, 2020,34(4): 23-27. doi:10.6040/j.issn.1673-3770.1.2020.059. WANG Luping, HUANG Yingxiang, WANG Yanling. Recent ocular ischemic syndrome advances[J]. J Otolaryngol Ophthalmol Shandong Univ, 2020,34(4): 23-27. doi:10.6040/j.issn.1673-3770.1.2020.059.
[16] Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment[J]. Stroke, 1993, 24(1): 35-41. doi:10.1161/01.str.24.1.35.
[17] Sun J, Zhao XQ, Balu N, et al. Carotid plaque lipid content and fibrous cap status predict systemic CV outcomes: the MRI substudy in AIM-HIGH[J]. JACC Cardiovasc Imaging, 2017, 10(3): 241-249. doi:10.1016/j.jcmg.2016.06.017.
[18] Barrett KM, Brott TG. Stroke caused by extracranial disease[J]. Circ Res, 2017, 120(3): 496-501. doi:10.1161/CIRCRESAHA.117.310138.
[19] Mizener JB, Podhajsky P, Hayreh SS. Ocular ischemic syndrome[J]. Ophthalmology, 1997, 104(5): 859-864. doi:10.1016/s0161-6420(97)30221-8.
[20] Mendrinos E, Machinis TG, Pournaras CJ. Ocular ischemic syndrome[J]. Surv Ophthalmol, 2010, 55(1): 2-34. doi:10.1016/j.survophthal.2009.02.024.
[21] Helenius J, Arsava EM, Goldstein JN, et al. Concurrent acute brain infarcts in patients with monocular visual loss[J]. Ann Neurol, 2012, 72(2): 286-293. doi:10.1002/ana.23597.
[22] Benavente O, Eliasziw M, Streifler JY, et al. Prognosis after transient monocular blindness associated with carotid-artery Stenosis[J]. N Engl J Med, 2001, 345(15): 1084-1090. doi:10.1056/NEJMoa002994.
[23] Abel AS, Suresh S, Hussein HM, et al. Practice patterns after acute embolic retinal artery occlusion[J]. Asia Pac J Ophthalmol(Phila), 2017, 6(1): 37-39. doi:10.22608/APO.201690.
[24] Biousse V. Acute retinal arterial ischemia: an emergency often ignored[J]. Am J Ophthalmol, 2014, 157(6): 1119-1121. doi:10.1016/j.ajo.2014.02.018.
[25] Chen CS, Miller NR. Ocular ischemic syndrome: review of clinical presentations, etiology, investigation, and management[J]. Compr Ophthalmol Update, 2007, 8(1): 17-28.
[26] Mitchell P, Wang JJ, Wong TY, et al. Retinal microvascular signs and risk of stroke and stroke mortality[J]. Neurology, 2005, 65(7): 1005-1009. doi:10.1212/01.wnl.0000179177.15900.ca.
[27] McGeechan K, Liew G, MacAskill P, et al. Prediction of incident stroke events based on retinal vessel caliber: a systematic review and individual-participant meta-analysis[J]. Am J Epidemiol, 2009, 170(11): 1323-1332. doi:10.1093/aje/kwp306.
[28] de Silva DA, Manzano JJ, Liu EY, et al. Retinal microvascular changes and subsequent vascular events after ischemic stroke[J]. Neurology, 2011, 77(9): 896-903. doi:10.1212/WNL.0b013e31822c623b.
[29] Su CW, Chang YC, Lin CL, et al. Association of neovascular Glaucoma with risk of stroke: a population-based cohort study[J]. J Ophthalmol, 2017: 1851568. doi:10.1155/2017/1851568.
[30] Wang WZ, Jiang B, Sun HX, et al. Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults[J]. Circulation, 2017, 135(8): 759-771. doi:10.1161/CIRCULATIONAHA.116.025250.
[31] Sand KM, Midelfart A, Thomassen L, et al. Visual impairment in stroke patients: a review[J]. Acta Neurol Scand Suppl, 2013(196): 52-56. doi:10.1111/ane.12050.
[32] Ong YT, de Silva DA, Cheung CY, et al. Microvascular structure and network in the Retina of patients with ischemic stroke[J]. Stroke, 2013, 44(8): 2121-2127. doi:10.1161/STROKEAHA.113.001741.
[33] 刘喆, 赵露, 谢国丽, 等. 颈动脉狭窄患者眼血流动力学参数对缺血性脑血管疾病风险的评估[J]. 中华眼科杂志, 2014, 50(12): 894-899. doi:10.3760/cma.j.issn.0412-4081.2014.12.005. LIU Zhe, ZHAO Lu, XIE Guoli, et al. Evaluating the risk of ischemic cerebral vascular disease with ocular hemodynamics in carotid artery Stenosis patients[J]. Chin J Ophthalmol, 2014, 50(12): 894-899. doi:10.3760/cma.j.issn.0412-4081.2014.12.005.
[34] Steele EC Jr, Guo QM, Namura S. Filamentous middle cerebral artery occlusion causes ischemic damage to the Retina in mice[J]. Stroke, 2008, 39(7): 2099-2104. doi:10.1161/STROKEAHA.107.504357.
[35] Tsai CL, Lee JT, Cheng CA, et al. Reversal of ophthalmic artery flow as a predictor of intracranial hemodynamic compromise: implication for prognosis of severe carotid Stenosis[J]. Eur J Neurol, 2013, 20(3): 564-570. doi:10.1111/ene.12038.
[36] Lin CM, Liu CK, Chang YJ, et al. Reversed ophthalmic artery flow following ischemic stroke: a possible predictor of outcomes following carotid artery stenting[J]. Neurol Res, 2019, 41(2): 132-138. doi:10.1080/01616412.2018.1544744.
[37] Sung YF, Tsai CL, Lee JT, et al. Reversal of ophthalmic artery flow and stroke outcomes in Asian patients with acute ischemic stroke and unilateral severe cervical carotid Stenosis[J]. PLoS One, 2013, 8(12): e80675. doi:10.1371/journal.pone.0080675.
[38] Klijn CJ, Kappelle LJ, van Schooneveld MJ, et al. Venous stasis retinopathy in symptomatic carotid artery occlusion: prevalence, cause, and outcome[J]. Stroke, 2002, 33(3): 695-701. doi:10.1161/hs0302.104619.
[39] Geiseler S, Morland C. The Janus face of VEGF in stroke[J]. Int J Mol Sci, 2018, 19(5): 1362. doi:10.3390/ijms19051362.
[40] Wang YM, Kilic E, Kilic U, et al. VEGF overexpression induces post-ischaemic neuroprotection, but facilitates haemodynamic steal phenomena[J]. Brain, 2005, 128(Pt 1): 52-63. doi:10.1093/brain/awh325.
[41] Lee SC, Lee KY, Kim YJ, et al. Serum VEGF levels in acute ischaemic strokes are correlated with long-term prognosis[J]. Eur J Neurol, 2010, 17(1): 45-51. doi:10.1111/j.1468-1331.2009.02731.x.
[42] Simha A, Aziz K, Braganza A, et al. Anti-vascular endothelial growth factor for neovascular Glaucoma[J]. Cochrane Database Syst Rev, 2020, 2: CD007920. doi:10.1002/14651858.CD007920.pub3.
[43] Kowalczuk L, Touchard E, Omri S, et al. Placental growth factor contributes to micro-vascular abnormalization and blood-retinal barrier breakdown in diabetic retinopathy[J]. PLoS One, 2011, 6(3): e17462. doi:10.1371/journal.pone.0017462.
[44] Ma FY, Su J, Shang QL, et al. Changes in ocular hemodynamics after carotid artery angioplasty and stenting(CAAS)in patients with different severity of ocular ischemic syndrome[J]. Curr Eye Res, 2018, 43(2): 266-272. doi:10.1080/02713683.2017.1390771.
[45] Halliday A, Mansfield A, Marro J, et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial[J]. Lancet, 2004, 363(9420): 1491-1502. doi:10.1016/S0140-6736(04)16146-1.
[46] Hormese M, Wichter M. Vitreo-retinal hemorrhage after thrombolysis in a patient with acute ischemic stroke: a case report[J]. Front Neurol, 2012, 3: 71. doi:10.3389/fneur.2012.00071.
[1] LI Yingying, FENG JieOverview,LI Wei, DING TianjiaoGuidance. Effects of ischemic stroke and other neurodegenerative diseases on RNFL thickness [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(2): 163-168.
[2] FAN HuijuanOverview,ZHANG HailiGuidance. Advancements of HIF-1α and VEGF in middle ear cholesteatoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(5): 93-97.
[3] Ocular ischemic syndrome(OIS)is a severe ophthalmic disease caused by ocular hypoperfusion, which occurs due to stenosis or occlusion of the common or internal carotid arteries. The clinical presentations and signs of OIS are complex, incidental, and different. OIS is easily misdiagnosed or remains undiagnosed because of its asymptomatic onset and complicated ocular manifestations. Therefore, it is crucial to trace the etiology of OIS. Presently, different imaging modalities can evaluate the carotid artery blood supply, collateral circulation, and brain perfusion. Thus, appropriate modalities must be selected for OIS diagnosis based on their advantages and disadvantages. Furthermore, the auxiliary examination results should be accurately and promptly considered and interpreted when establishing a diagnosis of OIS. Thus, the management of OIS requires cooperation with ophthalmologists, cardiologists, and neurologists.. Correct interpretation of the predictors of ocular ischemic syndrome to improve diagnostic performance HUANG Yingxiang, WANG Yanling Department of Ophthalmology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China Abstract: [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(4): 1-4.
[4] Carotid artery stenosis is a common clinical disorder. Its main clinical symptoms are transient ischemic attacks and cerebral infarction, ocular ischemic syndrome(OIS)is rare. Its diagnostic imaging modalities include doppler ultrasound imaging, CTA, and MRA. Medical therapy, including risk factor management of atherosclerosis, is necessary for all patients with carotid artery stenosis. Carotid revascularization techniques, including carotid endarterectomy or carotid artery stenting, should be performed for asymptomatic patients with severe carotid artery stenosis and symptomatic patients with moderate carotid stenosis. Patients with carotid artery stenosis need early interventions to prevent stroke, improve ocular artery perfusion, and, ultimately, prevent further vision loss.. Advances in the diagnosis and treatment of carotid artery stenosisXU Zeqin Overview GUO Lianrui Guidance Department of Vascular Surgery, Xuan Wu Hospital and Institute of Vascular Surgery, Capital Medical University, Beijing 100053, ChinaAbstract: [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(4): 11-15.
[5] Ocular ischemic syndrome(OIS)is usually undiagnosed or misdiagnosed due to its asymptomatic onset, complicated ocular manifestations, and the lack of awareness, and patients with OIS have a higher mortality. Improving the understanding, diagnosis, and treatment of OIS through multidisciplinary collaboration is key to investigating and preventing systemic vascular events as well as decreasing blindness and mortality. This review summarizes the recent advances in the epidemiology, clinical diagnosis, and management of OIS.. Recent ocular ischemic syndrome advancesWANG Luping Overview HUANG Yingxiang, WANG Yanling Guidance Department of Ophthalmology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, ChinaAbstract: [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(4): 23-27.
[6] ObjectiveObjectiveTo analyze the literature on ocular ischemic syndrome published between January , and December , . MethodPapers on OIS that were published between January , and December , , were screened and retrieved from the CNKI and WOS databases, and those that were relevant were searched and analyzed. ResultsIn this analysis, Chinese papers on OIS were cited for times with an h-index of , while foreign papers were cited for times with an h-index of . Of the organizations that published the highest number of papers and had the highest h-indexes, the Capital Medical University and the Polish Medical University of Pomerania were the leading institutions. The Chinese Journal of Ophthalmology was the leading domestic journal, and the Journal of Ophthalmology and Plos One were the leading foreign journals. China published the highest number of papers abroad, China and South Korea had the highest h-indexes. China′s National Natural Science Foundation provided the most support to the field of OIS, accounting for .% of the total domestic literature. The most frequently cited article in the WOS database was by Hayreh, SS, which was on the prevalence and pathogenesis of ocular vascular occlusive disease and melanosis, it was also part of the top ten studies that focused on the utility of OCT in providing insights into OIS and the mechanisms of ischemia and hypoxia. ConclusionThe utility of OCT in providing insights into OIS and the mechanisms of hypoxia and ischemia represents a modern focus of researchers.. Analysis of the literature on ocular ischemic syndrome at home and abroadMENG Bo, HUANG Yingxiang, WANG Kang, ZHAO Lu, WANG Yanling Department of Ophthalmology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, ChinaAbstract: [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(4): 35-40.
[7] ObjectiveTo discuss the causes and appropriate treatment for iris neovascularization following the analysis of cases( eyes). MethodsIt was a retrospective case series study involving patients( eyes)with iris neovascularization diagnosed between September and July . All the patients underwent ophthalmic examination, and all the examination findings and treatments were recorded. The causes, correlative factors, and treatment outcomes of iris neovascularization were analyzed. ResultsOf the patients, ( eyes, .%)had retinal ischemic signs, including vitreous hemorrhage and retinal vascularization on fundus fluorescein angiography, ( eyes, .%)did not have retinal ischemic signs. After months of treatment, retinal vascularization resolved in all the cases, and iris neovascularization resolved completely in patients( eyes, .%), iris neovascularization was still found in patients( eyes, .%). ConclusionsAnterior segment ischemia may also lead to iris vascularization, although retinal ischemia was the main cause. Additionally, iris neovascularization may not always resolve with treatment for retinal ischemia. Finally, anti-VEGF drug injection was an effective treatment for iris neovascularization.. Case analysis of 25 cases of iris neovascularizationLI Xuan1,2, HUANG Yingxiang2 1. Department of Ophthalmology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China; 2. Department of Fundus Disease and Eye Trauma, Eye Hospital China Academy of Chinese Medicine Sciences, Beijing 100040, ChinaAbstract: [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(4): 41-47.
[8] ObjectiveTo discuss the early diagnosis and multidisciplinary diagnosis and treatment of neovascular glaucoma in ocular ischemic syndrome. MethodsThe medical records of a 54-year-old male patient with cerebral infarction who presented with right-eye vision loss that had persisted for a week were reviewed. After slit-lamp examination and fluorescence angiography, he was diagnosed with ocular ischemic syndrome(OIS)complicated by neovascular glaucoma in the right eye and treated with intravitreal injection of anti-VEGF drugs and panretinal photocoagulation. ResultsAfter three months of treatment, the right-eye iris neovascularization subsided, and the intraocular pressure was controlled within normal limits. ConclusionOcular ischemia is often missed or misdiagnosed by ophthalmologists, neurologists, cardiologists, and vascular surgeons due to its insidious onset and complex clinical manifestations. Therefore, the establishment of multidisciplinary diagnosis and treatment can improve the prognosis of OIS patients.. Neovascular glaucoma in ocular ischemic syndrome: a case report and literature reviewQIN Shuqi1, WANG Luping1, JIANG Bin2, WANG Yanling1 1. Department of Ophthalmology, Beijing Friendship Hospital, Capital Medical University, Beijing 10050, China; 2. Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing 10050, ChinaAbstract: [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(4): 53-55.
[9] Spectral-domain optical coherence tomography(SD-OCT)was used to measure and observe the characteristics of the subfoveal choroidal thickness(SFCT)in patients with ocular ischemic syndrome(OIS)as well as explore the indicators for early evaluation of OIS. MethodsThis was a retrospective case-control study. Forty-eight patients(48 eyes)were included between January 2017 and January 2020. The patients were divided into two groups: the OIS and the control groups, with each consisting of 24 patients(24 eyes). Their basic information, including age, gender, body mass index(BMI), and the history of diabetes, hypertension, and hyperlipidemia, was collected. SFCT was measured using SD-OCT in EDI mode. The basic data and SFCTs of the two groups were compared. ResultsThere were no significant differences between the ages, gender, BMIs, and the prevalence of diabetes, hypertension, and hyperlipidemia of the two groups(all P>0.05). The mean SFCT of the OIS group was 204.83±27.34 μm, and that of the control group was 226.58±33.49 μm. The differences between the two groups were statistically significant(t=2.464, P=0.018). ConclusionsSFCT was thinner in patients with OIS. SFCT can be used as an indicator for early assessment of OIS.. Analysis of choroidal thickness in patients with ocular ischemic syndromeFU Qiang, WANG Hongxing Department of Ophthalmology, Beijing Chuiyangliu Hospital, Beijing 100022, ChinaAbstract: Objective〓 [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(4): 60-63.
[10] YANG Xiufen, LI Hongyang, ZHAO Lu,WEI Ying, HU Xiangdong, CHEN Jun, WANG Yanling. Clinical and imaging characteristics in patients with ocular ischemic syndrome [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(4): 119-123.
[11] LI Hao, LI Yanzhong, WANG Yan. Hypoxia inducible factor-1 alpha and vascular endothelial growth factor expression in the soft palate of [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(2): 43-47.
[12] WANG Cui, YAN Xin, ZHAO Bojun. Combination of intravitreal ranibizumab with photodynamic therapy in the treatment of wet age-related macular degeneration. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(4): 94-97.
[13] . Effects of PGMS on the expression of vascular endothelial growth factor in the rat of diabetic retinopathy. [J]. J Otolaryngol Ophthalmol Shandong Univ, 2017, 31(2): 90-95.
[14] LI Yingying, ZHOU Han, ZHANG Weiqiang, DONG Weida. Effects of silencing hypoxia inducible factor-1α on the expression of cytokines in cultured human nasal epithelial cells [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(5): 38-42.
[15] LI Junying. Effects of rosuvastatin combined with fenofibrate therapy on vascular endothelial function retinopathy diabetic retinopathy patients [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(5): 72-75.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd